Injury healing requires orchestrated phases: hemostasis, inflammation, proliferation, and remodeling. Inadequate healing — whether from acute trauma, overuse, or age-related repair deficits — results in chronic injury, scar tissue, and re-injury risk. Peptide research accelerates every phase of the healing cascade, from initial angiogenesis to final collagen remodeling.
1. BPC-157 — Universal Repair Accelerator
BPC-157 is the most versatile healing peptide studied. It upregulates growth hormone receptors at injury sites, promotes angiogenesis, reduces inflammation, and accelerates healing of muscle, tendon, ligament, bone, and nerve tissue. Its effects span the entire healing cascade from acute inflammation control to final scar remodeling.
Dosing Protocol: 250–500 mcg SubQ daily, injected as close to the injury site as practical. Oral BPC-157 (500 mcg arginate) for GI injuries. Cycle: 4–8 weeks or until healed.
2. TB-500 — Systemic Tissue Repair
TB-500 (Thymosin Beta-4) promotes the migration of repair cells (fibroblasts, endothelial cells) to injury sites via actin regulation, reduces inflammatory adhesion formation, and accelerates healing of soft tissue structures throughout the body. It is particularly effective for injuries that BPC-157 doesn’t penetrate well due to location.
Dosing Protocol: 2–2.5 mg SubQ twice weekly for 4–6 weeks (loading), then 2 mg weekly. Combine with BPC-157 for synergistic full-spectrum healing.
3. GHK-Cu — Collagen / Matrix Remodeling
GHK-Cu drives the remodeling phase of healing by stimulating organized collagen synthesis, activating MMPs that clear damaged tissue, and promoting elastin regeneration. It ensures the healed tissue has structural integrity rather than weak scar collagen, reducing re-injury risk.
Dosing Protocol: 1–2 mg SubQ daily at or near injury site. Topical application for surface injuries. Cycle: 8 weeks.
4. IGF-1 LR3 — Cellular Proliferation Phase
IGF-1 LR3 powerfully drives the proliferative phase of healing — stimulating the rapid cell division of fibroblasts, satellite cells, and chondrocytes needed to rebuild damaged tissue. It amplifies the effects of BPC-157 and TB-500 by providing the growth factor signal for cellular multiplication.
Dosing Protocol: 20–40 mcg SubQ daily, near injury site if practical. Cycle: 4 weeks on, 4 weeks off.
BPC-157 and TB-500 cover immediate healing acceleration from complementary angles — BPC-157 targeting local repair signaling and TB-500 driving cell migration to the injury. GHK-Cu ensures the rebuilding phase produces quality organized tissue. IGF-1 LR3 amplifies cellular proliferation, accelerating the timeline from injury to full structural repair.
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).